Science Explorer Back to mapMap
Discussion
Researcher · Kushiro Rosai Hospital · Japan

Kentaro Sawada

Kentaro Sawada publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Cancer Treatment and Pharmacology.

ORCID 0000-0001-7952-2765 OpenAlex
World rank
#2,853,736
of 7,710,434 ranked researchers
Rank in Japan
#61,989
of 383,136
Works
202
Citations
1.4k
Citations per work
6.9
h-index
15
i10-index 25Top 36% in Oncology
Kentaro Sawada

What does Kentaro Sawada research?

Kentaro Sawada's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 139 works · 68.7% of their workMedicine: 139 works · 68.7% of their workOncology: 56 works · 27.5% of their workPulmonary and Respiratory Medicine: 43 works · 21.1% of their workSurgery: 34 works · 17.0% of their workPathology and Forensic Medicine: 6 works · 3.1% of their workEverything else: 49 works · 24.3% of their workLife Sciences: 14 works · 7.0% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 7.0% of their workCancer Research: 8 works · 4.1% of their workMolecular Biology: 6 works · 2.9% of their workTHEIR WORKKentaro Sawada202works
Life Sciences7%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13968.7%
  2. Everything else4924.3%
    1. Biochemistry, Genetics and Molecular Biology147.0%
  1. 1Oncology28% of their works
  2. 2Pulmonary and Respiratory Medicine21% of their works
  3. 3Surgery17% of their works
  4. 4Cancer Research4% of their works
  5. 5Pathology and Forensic Medicine3% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Kentaro Sawada's research?

The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Molecular Characterization, Gastric Cancer, Lymph Node Dissection, Cetuximab, KRAS Mutations and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy1293 topics
  2. Endoscopic Resection722 topics
  3. Molecular Characterization682 topics
  4. Gastric Cancer571 topic
  5. Lymph Node Dissection571 topic
  6. Cetuximab561 topic
  7. KRAS Mutations561 topic
  8. Targeted Therapy432 topics
  9. Neoadjuvant Therapy312 topics
  10. Chemotherapy-Induced Peripheral Neuropathy241 topic
  11. Taxanes241 topic
  12. ALK Inhibitors231 topic
  13. EGFR Mutations231 topic
  14. Cancer Genomics201 topic
  15. Mutational Signatures201 topic
  16. Pancreatic Cancer161 topic
  17. Surgical Complications161 topic
  18. Esophageal Carcinoma151 topic
  19. Preoperative Chemoradiotherapy151 topic
  20. Hereditary Syndromes111 topic
  21. Microsatellite Instability111 topic

Where does Kentaro Sawada work?

Kentaro Sawada's main affiliation in the publication record is Kushiro Rosai Hospital, Japan.

How many publications and citations does Kentaro Sawada have?

OpenAlex counts 202 works and 1,389 citations for Kentaro Sawada, an h-index of 15, ranking #2,853,736 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kentaro Sawada. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.